DEPDC1 was firstly reported in bladder cancer with aberrantly high expression; it acted as a transcriptional repressor by forming a complex with zinc finger protein 224 (ZNF224) to suppress A20 transcription, leading to the activation of anti-apoptotic pathway through activating NF-κB pathway (10). This evidence concerns the gene DEPDC1 and urinary bladder carcinoma.